Preventability of Adverse Drug Reactions Related to Antibiotics: An Assessment Based on Spontaneous Reporting System.
Adverse drug reactions
Antibiotic
Preventability
Spontaneous reporting system
pADRs
Journal
Therapeutic innovation & regulatory science
ISSN: 2168-4804
Titre abrégé: Ther Innov Regul Sci
Pays: Switzerland
ID NLM: 101597411
Informations de publication
Date de publication:
09 2023
09 2023
Historique:
received:
30
11
2022
accepted:
13
06
2023
medline:
4
8
2023
pubmed:
30
6
2023
entrez:
30
6
2023
Statut:
ppublish
Résumé
Antibiotics are commonly used in both outpatient and inpatient settings and are responsible for the majority of adverse drug reaction (ADR) reports. We aimed to characterize spontaneously reported ADRs associated with antibiotics and assessing the preventability of these ADRs in a Vietnamese setting. We conducted a retrospective descriptive study based on ADRs related to antibiotics spontaneously reported by healthcare workers to the National Pharmacovigilance Database of Vietnam (NPDV) between June 2018 and May 2019. The characteristics of included reports were descriptively analyzed. The preventability of reported ADRs was assessed using a standardized preventability scale. We identified the leading causes and described the characteristics associated with preventable ADRs (pADRs). We included 6385 antibiotic-related reports from a total of 12,056 reports submitted to the NPDV during the study period. Beta-lactam antibiotics, mostly broad-spectrum with parenteral route, were suspected in the majority cases. The most commonly reported pADRs were allergic reactions, mostly classified under skin and subcutaneous tissue disorders. Of all included cases, 537 cases (8.4%) were deemed as associated with pADRs. Major causes of pADRs include potentially inappropriate prescribing (352/537, 65.5%) and re-administration of antibiotics causing prior allergy/allergies (99/537, 18.4%). The majority of pADRs involved the use of beta-lactam antibiotics with inappropriate indications. ADRs related to antibiotic use represent more than half of ADRs spontaneously reported in Vietnam. Approximately one in every ten reported cases is associated with pADRs. The majority pADRs can be prevented through simple improvement in antibiotic prescribing practices.
Sections du résumé
BACKGROUND
Antibiotics are commonly used in both outpatient and inpatient settings and are responsible for the majority of adverse drug reaction (ADR) reports. We aimed to characterize spontaneously reported ADRs associated with antibiotics and assessing the preventability of these ADRs in a Vietnamese setting.
MATERIALS AND METHODS
We conducted a retrospective descriptive study based on ADRs related to antibiotics spontaneously reported by healthcare workers to the National Pharmacovigilance Database of Vietnam (NPDV) between June 2018 and May 2019. The characteristics of included reports were descriptively analyzed. The preventability of reported ADRs was assessed using a standardized preventability scale. We identified the leading causes and described the characteristics associated with preventable ADRs (pADRs).
RESULTS
We included 6385 antibiotic-related reports from a total of 12,056 reports submitted to the NPDV during the study period. Beta-lactam antibiotics, mostly broad-spectrum with parenteral route, were suspected in the majority cases. The most commonly reported pADRs were allergic reactions, mostly classified under skin and subcutaneous tissue disorders. Of all included cases, 537 cases (8.4%) were deemed as associated with pADRs. Major causes of pADRs include potentially inappropriate prescribing (352/537, 65.5%) and re-administration of antibiotics causing prior allergy/allergies (99/537, 18.4%). The majority of pADRs involved the use of beta-lactam antibiotics with inappropriate indications.
CONCLUSION
ADRs related to antibiotic use represent more than half of ADRs spontaneously reported in Vietnam. Approximately one in every ten reported cases is associated with pADRs. The majority pADRs can be prevented through simple improvement in antibiotic prescribing practices.
Identifiants
pubmed: 37389792
doi: 10.1007/s43441-023-00552-y
pii: 10.1007/s43441-023-00552-y
doi:
Substances chimiques
Anti-Bacterial Agents
0
beta-Lactams
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1104-1112Informations de copyright
© 2023. The Author(s), under exclusive licence to The Drug Information Association, Inc.
Références
Morimoto T, Gandhi T, Seger A, Hsieh T, Bates D. Adverse drug events and medication errors: detection and classification methods. BMJ Qual Saf. 2004;13(4):306–14.
doi: 10.1136/qshc.2004.010611
European Medicines Agency. Good practice guide on recording, coding, reporting and assessment of medication errors. 2015. https://www.ema.europa.eu/en/documents/regulatory-procedural-guideline/good-practice-guide-recording-coding-reporting-assessment-medication-errors_en.pdf . Accessed 6 Mar 2022.
Krahenbuhl-Melcher A, Schlienger R, Lampert M, Haschke M, Drewe J, Krahenbuhl S. Drug-related problems in hospitals: a review of the recent literature. Drug Saf. 2007;30(5):379–407.
doi: 10.2165/00002018-200730050-00003
pubmed: 17472418
Howard RL, Avery AJ, Slavenburg S, Royal S, Pipe G, Lucassen P, et al. Which drugs cause preventable admissions to hospital? A systematic review. Br J Clin Pharmacol. 2007;63(2):136–47.
doi: 10.1111/j.1365-2125.2006.02698.x
pubmed: 16803468
Villanueva P, Coffin SE, Mekasha A, McMullan B, Cotton MF, Bryant PA. Comparison of antimicrobial stewardship and infection prevention and control activities and resources between low-/middle-and high-income countries. Pediatr Infect Dis J. 2022;41(3):S3–9.
doi: 10.1097/INF.0000000000003318
pubmed: 35134034
pmcid: 8815833
Hakkarainen KM, Sundell KA, Petzold M, Hägg S. Methods for assessing the preventability of adverse drug events. Drug Saf. 2012;35(2):105–26.
doi: 10.2165/11596570-000000000-00000
pubmed: 22201475
Olivier P, Boulbés O, Tubery M, Lauque D, Montastruc J-L, Lapeyre-Mestre M. Assessing the feasibility of using an adverse drug reaction preventability scale in clinical practice. Drug Saf. 2002;25(14):1035–44.
doi: 10.2165/00002018-200225140-00005
pubmed: 12408734
Imbs J, Pletan Y, Spriet A. Evaluation de la iatrogénèse médicamenteuse évitable: méthodologie. Thérapie (Paris). 1998;53(4):365–70.
pubmed: 9806006
Imbs J, Pouyanne P, Haramburu F, Welsch M, Decker N, Blayac J. Iatrogénie médicamenteuse: estimation de sa prévalence dans les hôpitaux publics français. Thérapie (Paris). 1999;54(1):21–7.
pubmed: 10216418
Sulis G, Daniels B, Kwan A, Gandra S, Daftary A, Das J, et al. Antibiotic overuse in the primary health care setting: a secondary data analysis of standardised patient studies from India, China and Kenya. BMJ Glob Health. 2020;5(9):e003393.
doi: 10.1136/bmjgh-2020-003393
pubmed: 32938614
pmcid: 7493125
Nguyen KD, Vu DH, Nguyen HA, Dao VT, Montastruc JL, Bagheri H. Risk comparison of beta-lactam-induced anaphylaxis: therapeutic stratification analysis in a Vietnamese pharmacovigilance database. J Clin Pharm Ther. 2021;46(4):950–6.
doi: 10.1111/jcpt.13376
pubmed: 33565097
Nguyen KD, Nguyen HA, Vu DH, Le TTL, Dang BV, Nguyen TN, et al. Drug-induced anaphylaxis in a Vietnamese pharmacovigilance database: trends and specific signals from a disproportionality analysis. Drug Saf. 2019;42(5):671–82.
doi: 10.1007/s40264-018-0758-8
pubmed: 30478823
Aagaard L, Strandell J, Melskens L, Petersen PS, Holme HE. Global patterns of adverse drug reactions over a decade: analyses of spontaneous reports to VigiBase. Drug Saf. 2012;35(12):1171–82.
doi: 10.1007/BF03262002
pubmed: 23072620
Kanjanarat P, Winterstein AG, Johns TE, Hatton RC, Gonzalez-Rothi R, Segal R. Nature of preventable adverse drug events in hospitals: a literature review. Am J Health Syst Pharm. 2003;60(17):1750–9.
doi: 10.1093/ajhp/60.17.1750
pubmed: 14503111
Karimian Z, Kheirandish M, Javidnikou N, Asghari G, Ahmadizar F, Dinarvand R. Medication errors associated with adverse drug reactions in Iran (2015–2017): a P-method approach. Int J Health Policy Manag. 2018;7(12):1090.
doi: 10.15171/ijhpm.2018.91
pubmed: 30709084
pmcid: 6358654
Nguyen KD, Nguyen PT, Nguyen HA, Roussin A, Montastruc JL, Bagheri H, et al. Overview of pharmacovigilance system in Vietnam: lessons learned in a resource-restricted Country. Drug Saf. 2018;41(2):151–9.
doi: 10.1007/s40264-017-0598-y
pubmed: 28975584
The Uppsala Monitoring Center. WHO adverse reaction terminology—WHO-ART. Sweden: TUM; 2012.
WHO Collaborating Centre for Drug Statistics Methodology. Structure and principles. 2005. https://www.whocc.no/atc/structure_and_principles/ . Accessed 6 Mar 2022.
World Health Organization (WHO), Uppsala Monitoring Centre (UMC). The use of the WHO-UMC system for standardised case causality assessment. 2013. https://www.who.int/medicines/areas/quality_safety/safety_efficacy/WHOcausality_assessment.pdf . Accessed 6 Mar 2022.
US Department of Health and Human Services. Common terminology criteria for adverse events (CTCAE) Version 5.0. 2017. https://ctep.cancer.gov/protocoldevelopment/electronic_applications/docs/ctcae_v5_quick_reference_5x7.pdf . Accessed 6 Mar 2022.
World Health Organization. ICD-10: international statistical classification of diseases and related health problems: tenth revision, 2nd ed. 2004. https://apps.who.int/iris/handle/10665/42980 . Accessed 6 Mar 2022.
European Medicines Agency. ICH M5 EWG routes of administration controlled vocabulary. 2005. https://www.ema.europa.eu/en/documents/scientific-guideline/ich-m-5-ewg-routes-administration-controlled-vocabulary-step-5_en.pdf . Accessed 6 Mar 2022.
Vu TVD, Do TTN, Rydell U, Nilsson LE, Olson L, Larsson M, et al. Antimicrobial susceptibility testing and antibiotic consumption results from 16 hospitals in Viet Nam: the VINARES project 2012–2013. J Global Antimicrob Res. 2019;18:269–78.
doi: 10.1016/j.jgar.2019.06.002
Hoa NQ, Chuc NTK, Phuc HD, Larsson M, Eriksson B, Lundborg CS. Unnecessary antibiotic use for mild acute respiratory infections during 28-day follow-up of 823 children under five in rural Vietnam. Trans R Soc Trop Med Hyg. 2011;105(11):628–36.
doi: 10.1016/j.trstmh.2011.07.015
Fair RJ, Tor Y. Antibiotics and bacterial resistance in the 21st century. Perspect Med Chem. 2014;6:25–64.
World Health Organization. Antimicrobial stewardship programmes in health-care facilities in low- and middle-income countries: a WHO practical toolkit. 2019. https://apps.who.int/iris/bitstream/handle/10665/329404/9789241515481-eng.pdf . Accessed 6 Mar 2022.
Van Nguyen K, Do NTT, Chandna A, Nguyen TV, Van Pham C, Doan PM, et al. Antibiotic use and resistance in emerging economies: a situation analysis for Viet Nam. BMC Public Health. 2013;13(1):1–10.
doi: 10.1186/1471-2458-13-1158
World Health Organization. Medication errors: technical series on safer primary care. 2016. https://apps.who.int/iris/bitstream/handle/10665/252274/9789241511643-eng.pdf . 6 Mar 2022.
Van Houten CB, Cohen A, Engelhard D, Hays JP, Karlsson R, Moore E, et al. Antibiotic misuse in respiratory tract infections in children and adults—a prospective, multicentre study (TAILORED Treatment). Eur J Clin Microbiol Infect Dis. 2019;38(3):505–14.
doi: 10.1007/s10096-018-03454-2
pubmed: 30707378
pmcid: 6394715
Cella M, Knibbe C, Danhof M, Della PO. What is the right dose for children? Br J Clin Pharmacol. 2010;70(4):597.
doi: 10.1111/j.1365-2125.2009.03591.x
pubmed: 21087295
pmcid: 2950994
Iftikhar S, Sarwar MR, Saqib A, Sarfraz M. Causality and preventability assessment of adverse drug reactions and adverse drug events of antibiotics among hospitalized patients: a multicenter, cross-sectional study in Lahore, Pakistan. PLoS ONE. 2018;13(6):e0199456.
doi: 10.1371/journal.pone.0199456
pubmed: 29949616
pmcid: 6021047
de Araújo BC, de Melo RC, de Bortoli MC, Bonfim JRDA, Toma TS. How to prevent or reduce prescribing errors: an evidence brief for policy. Front Pharmacol. 2019;10:1–7.
doi: 10.3389/fphar.2019.00439
Nga DTT, Chuc NTK, Hoa NP, Hoa NQ, Nguyen NTT, Loan HT, et al. Antibiotic sales in rural and urban pharmacies in northern Vietnam: an observational study. BMC Pharmacol Toxicol. 2014;15(1):1–10.
doi: 10.1186/2050-6511-15-6
Nguyen H-T, Nguyen T-D, van den Heuvel ER, Haaijer-Ruskamp FM, Taxis K. Medication errors in Vietnamese hospitals: prevalence, potential outcome and associated factors. PLoS ONE. 2015;10(9):e0138284.
doi: 10.1371/journal.pone.0138284
pubmed: 26383873
pmcid: 4575184